WeVote

Bill

WeVote Research Nonpartisan
Bill Summary · SB 1595

Legislative bill overview

SB 1595 relates to the medical use of cannabis in Hawaii, though the bill's specific provisions are not detailed in the available information. Based on its referral to Health and Human Services and Judiciary committees, it likely addresses regulatory, access, or operational aspects of Hawaii's existing medical cannabis program.

Why is this important

Medical cannabis policy affects patient access to treatment options, healthcare provider guidance, and the regulatory framework governing a growing industry. Changes to Hawaii's medical cannabis laws could impact thousands of registered patients and dozens of licensed dispensaries and cultivators operating in the state.

Potential points of contention

  • Patient access vs. regulatory oversight – Balancing expanded patient eligibility or product availability against safety and quality control concerns
  • Industry regulation – Questions about licensing requirements, cultivation limits, pricing controls, or business operational standards
  • Provider participation – Whether healthcare providers should be required, incentivized, or have discretion in recommending medical cannabis
  • Implementation costs – Administrative burden and funding for state agencies managing program expansion or changes

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.